Alexander J Hagan
Biographic Data
| ID | 8265808 |
|---|---|
| NAME | Alexander J Hagan |
| GIVEN NAMES | Alexander J |
| FAMILY NAME | Hagan |
| SIGNATURE | HAGAN A J |
| AFFILIATIONS | Newcastle upon Tyne Hospitals NHS Foundation Trust |
| ORCID | 0000-0002-3622-3949 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship
Methylphenidate has an established role in the management of attention-deficit hyperactivity disorder and attentional deficit secondary to brain injury. Increasingly, methylphenidate is considered for the attentional deficit in paediatric brain tumour survivors. A small number of studies have explored the benefit of methylphenidate in this population; however, studies are of short duration and do not address the impact of medium to long-term use …
No prominent works on this page.
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship
Methylphenidate has an established role in the management of attention-deficit hyperactivity disorder and attentional deficit secondary to brain injury. Increasingly, methylphenidate is considered for the attentional deficit in paediatric brain tumour survivors. A small number of studies have explored the benefit of methylphenidate in this population; however, studies are of short duration and do not address the impact of medium to long-term use …
Attention Deficit Hyperactivity Disorder (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Cognitive Functions and Memory (1 work) · Cohort (1 work) · Environmental health (1 work) · Genetics and Neurodevelopmental Disorders (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Methylphenidate (1 work)